Zoetis ZTS
NYSE ZTS
$73.04 +0.04 (+0.05%)
As of: Sep 17, 2026 · 3:59 PM EDT

Zoetis (ZTS) Operating Income Growth (3y) (2015 - 2026)

Analysis

Zoetis (ZTS) Operating Income Growth (3y) (2015 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc Growth (3y) (Qtr)
1 Idexx Laboratories 40.57 Bn 40.38 Bn 779.09 Mn 12.85%
2 Zoetis 30.57 Bn 28.90 Bn 1.05 Bn 4.24%
3 Elanco Animal Health 11.47 Bn 10.94 Bn 798.00 Mn 35.42%
4 Phibro Animal Health 1.43 Bn 1.35 Bn 134.40 Mn 26.54%
5 Immucell 87.38 Mn 78.52 Mn 2.44 Mn 51.59%
6 Zhengye Biotechnology Holding 64.40 Mn 57.30 Mn - -
7 Global Innovative Platforms 24.88 Mn 24.63 Mn - -350.08%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.24%
Mar 31, 2026 4.32%
Dec 31, 2025 -1.06%
Sep 30, 2025 9.75%
Jun 30, 2025 10.68%
Mar 31, 2025 5.15%
Dec 31, 2024 -2.48%
Sep 30, 2024 9.18%
Jun 30, 2024 10.75%
Mar 31, 2024 6.95%
Dec 31, 2023 0.00%
Sep 30, 2023 4.87%
Jun 30, 2023 11.51%
Mar 31, 2023 7.52%
Dec 31, 2022 -8.11%
Sep 30, 2022 56.63%
Jun 30, 2022 52.28%
Mar 31, 2022 49.56%
Dec 31, 2021 -10.00%
Sep 30, 2021 54.25%